x
Filter:
Filters applied
- Opioids
- SNRIRemove SNRI filter
Publication Date
Please choose a date range between 2009 and 2018.
Author
- Argoff, Charles E1
- Baron, Ralf1
- Bharucha, Adil E1
- Camilleri, Michael1
- Chakraborty, Subhankar1
- Gilron, Ian1
- Gourlay, Geoffrey K1
- Haanpää, Maija L1
- Hooten, W Michael1
- Jensen, Troels1
- Kent, Joel L1
- Miaskowski, Christine1
- Raja, Srinivasa N1
- Schmader, Kenneth E1
- Silvershein, Daniel I1
- Sletten, Christopher D1
- Wells, Christopher D1
Keyword
- TCA6
- tricyclic antidepressant6
- randomized controlled trial3
- RCT3
- serotonin-norepinephrine reuptake inhibitor3
- 5-HT2
- IBS2
- irritable bowel syndrome2
- nonsteroidal anti-inflammatory drug2
- NSAID2
- selective serotonin reuptake inhibitor2
- SSRI2
- 5-hydroxytryptamine1
- 5-hydroxytryptamine (serotonin)1
- ACC1
- ADL1
- ADR1
- AE1
- ATC1
- BP1
- BPI1
- Brief Pain Inventory1
- CBT1
- CFU1
Opioids
6 Results
- Thematic Review Series on Gastroenterological Diseases
Management Options for Irritable Bowel Syndrome
Mayo Clinic ProceedingsVol. 93Issue 12p1858–1872Published in issue: December, 2018- Michael Camilleri
Cited in Scopus: 47Irritable bowel syndrome (IBS) is associated with diverse pathophysiologic mechanisms. These mechanisms include increased abnormal colonic motility or transit, intestinal or colorectal sensation, increased colonic bile acid concentration, and superficial colonic mucosal inflammation, as well as epithelial barrier dysfunction, neurohormonal up-regulation, and activation of secretory processes in the epithelial layer. Novel approaches to treatment include lifestyle modification, changes in diet, probiotics, and pharmacotherapy directed to the motility, sensation, and intraluminal milieu of patients with IBS. - Symposium on pain medicine
Common Functional Gastroenterological Disorders Associated With Abdominal Pain
Mayo Clinic ProceedingsVol. 91Issue 8p1118–1132Published in issue: August, 2016- Adil E. Bharucha
- Subhankar Chakraborty
- Christopher D. Sletten
Cited in Scopus: 37Although abdominal pain is a symptom of several structural gastrointestinal disorders (eg, peptic ulcer disease), this comprehensive review will focus on the 4 most common nonstructural, or functional, disorders associated with abdominal pain: functional dyspepsia, constipation-predominant and diarrhea-predominant irritable bowel syndrome, and functional abdominal pain syndrome. Together, these conditions affect approximately 1 in 4 people in the United States. They are associated with comorbid conditions (eg, fibromyalgia and depression), impaired quality of life, and increased health care utilization. - Symposium on pain medicine
Chronic Pain and Mental Health Disorders: Shared Neural Mechanisms, Epidemiology, and Treatment
Mayo Clinic ProceedingsVol. 91Issue 7p955–970Published online: June 22, 2016- W. Michael Hooten
Cited in Scopus: 213Chronic pain and mental health disorders are common in the general population, and epidemiological studies suggest that a bidirectional relationship exists between these 2 conditions. The observations from functional imaging studies suggest that this bidirectional relationship is due in part to shared neural mechanisms. In addition to depression, anxiety, and substance use disorders, individuals with chronic pain are at risk of other mental health problems including suicide and cigarette smoking and many have sustained sexual violence. - Symposium on pain medicine
Neuropathic Pain: Principles of Diagnosis and Treatment
Mayo Clinic ProceedingsVol. 90Issue 4p532–545Published in issue: April, 2015- Ian Gilron
- Ralf Baron
- Troels Jensen
Cited in Scopus: 297Neuropathic pain is caused by disease or injury of the nervous system and includes various chronic conditions that, together, affect up to 8% of the population. A substantial body of neuropathic pain research points to several important contributory mechanisms including aberrant ectopic activity in nociceptive nerves, peripheral and central sensitization, impaired inhibitory modulation, and pathological activation of microglia. Clinical evaluation of neuropathic pain requires a thorough history and physical examination to identify characteristic signs and symptoms. - SUPPLEMENT ARTICLE
Treatment Considerations for Patients With Neuropathic Pain and Other Medical Comorbidities
Mayo Clinic ProceedingsVol. 85Issue 3SupplementS15–S25Published in issue: March, 2010- Maija L. Haanpää
- Geoffrey K. Gourlay
- Joel L. Kent
- Christine Miaskowski
- Srinivasa N. Raja
- Kenneth E. Schmader
- and others
Cited in Scopus: 72The efficacy of drugs for neuropathic pain has been established in randomized controlled trials that have excluded patients with comorbid conditions and those taking complex medications. However, patients with neuropathic pain frequently present with complex histories, making direct application of this evidence problematic. Treatment of neuropathic pain needs to be individualized according to the cause of the pain, concomitant diseases, medications, and other individual factors. Tricyclic antidepressants (TCAs), gabapentinoids, selective noradrenergic reuptake inhibitors, and topical lidocaine are the first-line choices; if needed, combination therapy may be used. - REVIEW
A Comparison of Long- and Short-Acting Opioids for the Treatment of Chronic Noncancer Pain: Tailoring Therapy to Meet Patient Needs
Mayo Clinic ProceedingsVol. 84Issue 7p602–612Published in issue: July, 2009- Charles E. Argoff
- Daniel I. Silvershein
Cited in Scopus: 101Management of chronic noncancer pain (CNCP) requires a comprehensive assessment of the patient, the institution of a structured treatment regimen, an ongoing reassessment of the painful condition and its response to therapy, and a continual appraisal of the patient's adherence to treatment. For many patients with CNCP, the analgesic regimen will include opioids. Physicians should consider the available evidence of efficacy, the routes of administration, and the pharmacokinetics and pharmacodynamics of the various formulations as they relate to the temporal characteristics of the patient's pain.